Posted on November 6, 202511/6/25
EVDAS 2026: From Regulatory Requirement to Signal Advantage
Posted on September 12, 20259/12/25
Ready, Set, Simplify: PV Without the Hassle
Posted on September 10, 20259/10/25
2026 CMS Proposed Rule: BFSF Changes and Potential Risks for Pharma Manufacturers
Posted on September 10, 20259/10/25
Navigating OBBBA: Why a Strong GP Team is Essential for Pharma Compliance
Posted on August 25, 20258/25/25
Evaluation of HTA Frameworks for In Vivo Diagnostics: Assessing Methodological Gaps and Implications for Market Access
Posted on July 21, 20257/21/25
Empowering Scientific Dialogue: Key Takeaways from the FDA’s SIUU Guidance
Posted on May 29, 20255/29/25
Navigating the Final FDA SIUU Guidance: Strategic Considerations for Scientific Exchange at ASCO and Other Congresses
Posted on May 15, 20255/15/25